Takeda, Covance and Quintiles Sign Strategic Pact

Covance and Quintiles will work in close partnership with Takeda for new compounds in therapeutic areas, according to their new strategic agreement.

Takeda’s Pharmaceutical Development Division has established strategic partnerships with Covance and Quintiles to plan and execute global development programs for new compounds in all therapeutic areas, except oncology.

Takeda will have access to Covance and Quintiles clinical development capabilities and central lab services, with each partner providing resources to support Takeda’s development pipeline. Takeda plans to use a global program-level sourcing strategy to increase operational efficiency. Through these relationships, Takeda will take on a fully virtual outsourcing model combining the expertise of all parties to help improve productivity and facilitate its global growth.

“Takeda is focused on growing its global drug development footprint, especially in Asia, while at the same time ensuring quality and increasing efficien